117 related articles for article (PubMed ID: 21970993)
1. Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease.
Mizuochi T; Kimura A; Shimizu N; Nishiura H; Matsushita M; Yoshino M
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):365-7. PubMed ID: 21970993
[TBL] [Abstract][Full Text] [Related]
2. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
Mayet IY
Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
[No Abstract] [Full Text] [Related]
3. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
[TBL] [Abstract][Full Text] [Related]
4. [Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
Schmid-Rüter E; Feist D; Wesch H; Rossner JA; Schärer K
Dtsch Med Wochenschr; 1973 Sep; 98(37):1698-703. PubMed ID: 4125854
[No Abstract] [Full Text] [Related]
5. Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan.
Eda K; Mizuochi T; Iwama I; Inui A; Etani Y; Araki M; Hara S; Kumagai H; Hagiwara SI; Murayama K; Murakami J; Shimizu N; Kodama H; Yasuda R; Takaki Y; Yamashita Y
J Gastroenterol Hepatol; 2018 Jan; 33(1):264-269. PubMed ID: 28452067
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study.
Marcellini M; Di Ciommo V; Callea F; Devito R; Comparcola D; Sartorelli MR; Carelli G; Nobili V
J Lab Clin Med; 2005 Mar; 145(3):139-43. PubMed ID: 15871305
[TBL] [Abstract][Full Text] [Related]
8. Early occurrence of hypertransaminasemia in a 13-month-old child with Wilson disease.
Iorio R; D'Ambrosi M; Mazzarella G; Varrella F; Vecchione R; Vegnente A
J Pediatr Gastroenterol Nutr; 2003 May; 36(5):637-8. PubMed ID: 12717088
[No Abstract] [Full Text] [Related]
9. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years.
Brewer GJ; Dick RD; Johnson VD; Fink JK; Kluin KJ; Daniels S
J Lab Clin Med; 2001 Mar; 137(3):191-8. PubMed ID: 11241029
[TBL] [Abstract][Full Text] [Related]
12. [The role of zinc in the initial treatment of Wilson's disease in children].
Cacić M; Percl M; Jadresin O; Kolacek S
Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
[TBL] [Abstract][Full Text] [Related]
13. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment.
Arnon R; Calderon JF; Schilsky M; Emre S; Shneider BL
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):596-602. PubMed ID: 17460493
[TBL] [Abstract][Full Text] [Related]
14. Failure of prophylactic zinc in Wilson disease.
Mishra D; Kalra V; Seth R
Indian Pediatr; 2008 Feb; 45(2):151-3. PubMed ID: 18310797
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
16. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
[TBL] [Abstract][Full Text] [Related]
17. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease.
Weiss KH; Gotthardt DN; Klemm D; Merle U; Ferenci-Foerster D; Schaefer M; Ferenci P; Stremmel W
Gastroenterology; 2011 Apr; 140(4):1189-1198.e1. PubMed ID: 21185835
[TBL] [Abstract][Full Text] [Related]
18. [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
Li T; Lin R; Du S; Qu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):19-21. PubMed ID: 9949235
[TBL] [Abstract][Full Text] [Related]
19. Relapse following withdrawal of D-penicillamine from combination (D-penicillamine + zinc) therapy in hepatic Wilson disease.
Panda K; Lal BB; Sood V; Khanna R; Alam S
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1017-1026. PubMed ID: 38695602
[TBL] [Abstract][Full Text] [Related]
20. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
